A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

NCT05294458 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Steatohepatitis
Type 2 Diabetes Mellitus (T2DM)
Chronic Kidney Disease

Interventions

DRUG: cotadutide solution for injection

Sponsor

AstraZeneca

Collaborators

[object Object]